Asma H. Baig
610  Ergebnisse:
Personensuche X
?
3

Removing Critical Gaps in Chemical Test Methods by Developi..:

Kortenkamp, Andreas ; Axelstad, Marta ; Baig, Asma H....
International Journal of Molecular Sciences.  21 (2020)  9 - p. 3123 , 2020
 
?
4

Identification of a novel allosteric GLP-1R antagonist HTL2..:

O'Brien, Alistair ; Andrews, Stephen P. ; Baig, Asma H....
Bioorganic & Medicinal Chemistry Letters.  29 (2019)  20 - p. 126611 , 2019
 
?
8

Formation and Dissociation of M₁ Muscarinic Receptor Dimers..:

Hern, Jonathan A. ; Baig, Asma H. ; Mashanov, Gregory I....
Proceedings of the National Academy of Sciences of the United States of America.  107 (2010)  6 - p. 2693-2698 , 2010
 
?
9

Formation and dissociation of M1muscarinic receptor dimers ..:

Hern, Jonathan A. ; Baig, Asma H. ; Mashanov, Gregory I....
Proceedings of the National Academy of Sciences.  107 (2010)  6 - p. 2693-2698 , 2010
 
?
10

Expression, Desensitization, and Internalization of the ACT..:

CLARK, ADRIAN J.L. ; BAIG, ASMA H. ; NOON, LUKE...
Annals of the New York Academy of Sciences.  994 (2003)  1 - p. 111-117 , 2003
 
?
11

Desensitization of the Y1 Cell Adrenocorticotropin Receptor:

Baig, Asma H. ; Swords, Francesca M. ; Noon, Luke A....
Journal of Biological Chemistry.  276 (2001)  48 - p. 44792-44797 , 2001
 
?
12

Evidenced-based approaches to support the development of en..:

Audouze, K. (Karine) ; Zgheib, E. (Elias) ; Abass, K. (Khaled)...
info:eu-repo/grantAgreement/EC/H2020/825762/EU/Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome pathways/EDCMET.  , 2021
 
1-15